Saturday, 7. November 2026 · Next update: 10:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
Time Horizon All Tomorrow Next Week Next Month Next Year Minimum Probability ≥ 50% ≥ 70% ≥ 90% Day View Today Tomorrow Day after tomorrow
Home RSS ↗
📈 Economy Hit ✦ AI

Bitcoin (BTC/USD) closes above $82,500 on NFP day (October 2, 2026)

Bitcoin trades at $84,307 on Oct 1, 2026 (CoinGecko). The $82,500 threshold is 2.1% below current price, providing a moderate buffer against NFP-day volatility. On BLS release day (Oct 2), a short-term USD-strength impulse could pressure crypto — especially if Non-Farm Payrolls significantly beat the bearish Cassandra forecast of sub-100k new jobs. Macro tailwind: ISM Manufacturing PMI for September printed a strong 54.8 surprise (released Oct 1, 2026), supporting a risk-on backdrop and limiting correction potential. No direct Polymarket market found for this specific level/date; probability derived from technical distance (2.1% buffer) and median NFP-day BTC volatility (±2–3%).

73%
Tomorrow · Predicted for 2. Oct 2026
💻 Technology ✦ AI

Ethereum (ETH/USD) closes above $3,500 per token on March 31, 2027

Ethereum trades at $2,680 on Oct 1, 2026 (CoinGecko). The $3,500 threshold is 30.6% above current price — achievable within 6 months but ambitious. Forecaster consensus for October 2026 alone: DailyForex $2,600–$3,100; CoinDCX $2,950; Changelly $3,045–$3,070 (minimum target). The $3,500 level thus represents a natural projection of October momentum into Q1 2027. Bullish drivers: ETH staking yields remain attractive; Layer-2 adoption (Base, Arbitrum, Optimism) accelerates network utilization; historical BTC halving cycle patterns favor altcoin rallies from Q4 2026. Headwinds: US SEC regulatory action, macro-driven risk aversion, or decoupling from BTC. No direct Polymarket market found for this horizon; 30% probability conservatively derived from forecaster spread and ETH volatility profile.

30%
Next Year · Predicted for 31. Mar 2027
⚽ Sports Hit ✦ AI

Baltimore Ravens defeat Atlanta Falcons (NFL Week 5 Sunday Night Football, October 11, 2026, Mercedes-Benz Stadium Atlanta)

Bookmaker odds imply ~65% win probability for the Baltimore Ravens at Atlanta (NFL Week 5, Oct 11, 2026, 8:20 PM ET, NBC Sunday Night Football). Ravens are favored as the road team at -4.5 points (O/U: 48.5) — an unusually large road spread reflecting the structural quality gap. Baltimore convincingly beat the Tennessee Titans in Week 4; Lamar Jackson leads one of the AFC's most efficient offenses. The Falcons enter their home game with limited momentum after a Week-4 defeat to the New Orleans Saints (MNF Oct 5 — Cassandra predicts Saints win). Primetime settings (NBC SNF) statistically favor the higher-quality team. No Polymarket market found for this game; 65% derived directly from the -4.5 spread.

65%
Next Week · Predicted for 11. Oct 2026
🍾 Beverages Hit ✦ AI

Constellation Brands (NYSE: STZ) reports Q2 FY2027 total net revenues above $2.60 billion — beats analyst consensus (earnings report October 6, 2026)

Constellation Brands reports Q2 FY2027 (June–August 2026) on October 6, 2026. Analyst consensus is approximately $2.54–2.57B (Yahoo Finance/Nasdaq range), with EPS consensus around $3.56–3.75. The company meaningfully beat Q1 FY2027 estimates (April 2026). The beer segment (Corona Extra, Modelo Especial, Pacifico) accounts for over 90% of revenues; Modelo recently held US beer volume market leadership. Despite the negative pre-earnings signal from Benzinga ('Likely to Report Lower Q2 Earnings', September 29, 2026) — which refers to a YoY EPS decline, not necessarily a consensus miss — pricing power in the premium segment and sustained share gains in the US Hispanic market support the case for another beat, here set ambitiously above $2.60B. No Polymarket quote available. STZ's historical beat rate over the last 8 quarters was approximately 62%; the probability of exceeding consensus by the full $60M+ margin is estimated at 35%.

35%
Next Week · Predicted for 6. Oct 2026
💻 Technology Miss ✦ AI

Nobel Prize in Chemistry 2026: Shankar Balasubramanian and David Klenerman (University of Cambridge) for the development of next-generation DNA sequencing (announcement October 7, 2026)

The Royal Swedish Academy of Sciences announces the Nobel Prize in Chemistry on October 7. Shankar Balasubramanian and David Klenerman (both University of Cambridge) are the main favorites on small, illiquid prediction markets (Kalshi, Polymarket) for their invention of Sequencing by Synthesis (SBS), the foundation of modern NGS platforms — above all Illumina — which has revolutionized personalized medicine, oncology, and infectious disease epidemiology. Other strongly backed candidates: Pieter Cullis (UBC) for lipid nanoparticle technology (mRNA vaccines) and the skeletal editing trio Sarpong/Levin/Miranda. Kalshi: Balasubramanian/Klenerman as frontrunners without published exact odds; market positioning per Chemistry World and The Scientist implies approximately 20–28% for this duo. Nobel committees historically act surprisingly; probability set at 25%.

25%
Next Week · Predicted for 7. Oct 2026
📈 Economy Miss ✦ AI

Nobel Prize in Economic Sciences 2026: Ariel Pakes (Harvard University) wins for contributions to empirical industrial organization (announcement October 12, 2026)

The Sveriges Riksbank Prize in Economic Sciences will be announced on October 12, 2026, at 11:45 CEST. On prediction market Kalshi (kxnobelecon-26), Ariel Pakes (Harvard) leads with 23% — confirmed by Octagon AI (also 23%) — ahead of Richard Blundell (UCL, 16%) and Susan Athey (Stanford, 16%). The Kalshi market is very thin (~$1,625 in trading volume), so odds should be weighted qualitatively. Pakes is known for the 'BLP approach' (Berry-Levinsohn-Pakes, 1995), which became the standard method for structural estimation in industrial organization with broad empirical application in antitrust law, competition policy, and consumer protection. Other candidates: Partha Dasgupta (Cambridge, environmental economics), Luigi Zingales (Chicago, corporate finance), Philippe Aghion (Harvard, growth theory). Kalshi sees 23% for Pakes; this prediction anchors to the market and sets probability conservatively at 20%, as Nobel committees historically diverge significantly from market favorites.

20%
Next Month · Predicted for 12. Oct 2026
⚽ Sports Hit ✦ AI

Alexander Zverev (Germany) wins the 2026 ATP Rolex Shanghai Masters (final October 18, 2026, confirmed by ATP.com or Eurosport by October 19, 2026)

The ATP Masters 1000 Shanghai (October 7–18, 2026, outdoor hard court, Qizhong Forest Sports City Arena) takes place for the first time in years without Jannik Sinner: the World No. 1 withdrew on September 30, 2026, with iliotibial band syndrome (right knee) — he will skip both Shanghai and Paris/Bercy. Alexander Zverev (World No. 2) becomes the de facto top seed and has enormous extra motivation: if Sinner misses both remaining Masters 1000 events, Zverev — currently trailing Sinner by approximately 1,370 ranking points — could take the World No. 1 spot with a title win in Shanghai. Zverev's serve-and-baseline game suits Shanghai's slower hardcourt; he is the reigning French Open finalist and won Shanghai in 2023. Robinhood Prediction Markets implies Zverev as the clear favorite in a wide-open field (Medvedev, Shelton, Auger-Aliassime, Cobolli) that became significantly more open due to Sinner's absence. Back-to-back Masters wins (Beijing Oct 6 + Shanghai Oct 18) are rare but achievable with elevated motivation. Probability: approximately 25%.

25%
Next Month · Predicted for 18. Oct 2026
⚽ Sports Hit ✦ AI

Arsenal FC wins Premier League home fixture against West Ham United (Matchday 7, 4 October 2026)

Arsenal are the defending 2025/26 Premier League champions and heavy favourites at home against West Ham United. West Ham sit 19th with −8 goal difference, winning only once in five away underdog appearances. Bookmaker moneyline (Arsenal −521, West Ham +1333) implies ~83.9% for an Arsenal win. Analyst score predictions lean toward a comfortable Arsenal victory (e.g. 3-0). Arsenal are also in strong form ahead of their UCL matchday 2 fixture against Lille on 13 October.

80%
Next Week · Predicted for 4. Oct 2026
💻 Technology Hit ✦ AI

TSMC reports September 2026 monthly revenue exceeding NT$500 billion (report date 8 October 2026)

TSMC posted a record August 2026 revenue of NT$514.806 billion (+53.3% YoY, +10.1% MoM). Cumulative Jan–Aug 2026 revenues: NT$3,386.87 billion (+39.3% YoY). Seasonal tailwinds from the Apple iPhone high season in September and sustained Nvidia/AMD orders support a similarly strong September figure. Estimated Sep-2025 base of NT$325–335 billion implies a +53% YoY September 2026 figure of ~NT$498–513 billion, making the NT$500 billion threshold approximately the median of that range. Headlines indicate another strong September ('can't keep up with demand'). No Polymarket price found for this specific threshold.

67%
Next Week · Predicted for 8. Oct 2026
📈 Economy Miss ✦ AI

Jibun Bank Japan Services PMI September 2026 (Final, 6 October 2026): confirms flash reading — above 52.5 points

The Jibun Bank/S&P Global Japan Services PMI flash estimate for September 2026 was 52.5 points (released 24 September 2026). The August 2026 final was also 52.5 points. Market consensus expects the September final at 52.3 points, a slight downward revision. Historically the final value deviates by ±0.2–0.4 points from flash; upward revisions occur less often. Probability of confirming or exceeding the 52.5 flash is approximately 62%. Japan's services sector is in a robust six-month expansion plateau. No Polymarket price available; calibration via consensus and historical flash-to-final revision patterns.

62%
Next Week · Predicted for 6. Oct 2026
💻 Technology Hit ✦ AI

ASML Holding N.V. reports Q3 FY2026 net sales above €11.5 billion (quarterly report approx. 14 October 2026)

ASML (NASDAQ/Euronext: ASML) guided Q3 2026 net sales to €11.0–12.0 billion at 55–57% gross margin. In Q2 2026 the company posted €9.3 billion net sales, beating guidance ('Q2 2026 beats guidance as AI demand lifts outlook'). Full-year 2026 guidance was raised to €43–45 billion net sales. Exceeding the guidance midpoint of €11.5 billion requires +23.7% sequential growth from Q2 — consistent with ASML's typical H2 seasonal strength driven by EUV system deliveries. Given the Q2 guidance beat and raised full-year outlook, a midpoint beat is plausible at ~62%. No specific Polymarket price found.

62%
Next Month · Predicted for 14. Oct 2026
⚽ Sports Miss ✦ AI

Real Madrid CF wins El Clásico against FC Barcelona (La Liga Matchday 10, Bernabéu, 25 October 2026)

Real Madrid host FC Barcelona in the first El Clásico of the 2026/27 season at the Bernabéu (approx. Matchday 10, 25 October). Real Madrid lead La Liga after nine matchdays by two points; Barcelona are the 2025/26 defending champions. Bookmaker odds imply ~48.8% Real Madrid win (moneyline −105), ~29.9% Barcelona win (+235), ~22.3% draw (+330, de-vigged). No Polymarket price for this specific fixture found; calibration anchored to DraftKings moneyline. Expert predictions are split: one analysis gives Barcelona a narrow edge (defending champions), another foresees 2-1 to Real Madrid; slight home advantage at the Bernabéu.

47%
Next Month · Predicted for 25. Oct 2026
💻 Technology Miss ✦ AI

Nobel Prize in Physiology or Medicine 2026: Emmanuel Mignot and Masashi Yanagisawa win for the discovery of the orexin system

Emmanuel Mignot (Stanford) and Masashi Yanagisawa (UT Southwestern/HHMI) independently discovered the orexin/hypocretin system, whose deficiency causes narcolepsy — one of the last major unsolved sleep-wake puzzles in neurobiology. Announcement: October 5, 2026, 11:30 CEST. Key calibration signal: the duo received the 2026 Albert Lasker Award for Basic Medical Research — historically the single most reliable Nobel predictor (~25% of Lasker laureates subsequently win the Nobel). Kalshi prices the GLP-1 team (Drucker/Holst/Mojsov, Ozempic pathway) at ~26% as the market leader; Mignot/Yanagisawa appear underpriced given the fresh Lasker signal. Counter-thesis: the societal impact of the GLP-1 discovery (global obesity epidemic) is enormous, which the Nobel Committee might exploit opportunistically.

22%
Next Week · Predicted for 5. Oct 2026